Zafirlukast | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Zafirlukast
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Zafirlukast

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 3 USDMF, 3 EU WC, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

8 API Suppliers
3 USDMF
3 EU WC
5 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

14 FDF Dossiers, 10 FDA Orange Book, 1 Europe, 1 South Africa, 2 Listed Dossiers

14 FDF Dossiers
10 FDA Orange Book
1 Europe
1 South Africa
2 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG

TABLET;ORAL - 10MG
TABLET;ORAL - 20MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 DKSH, 4 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 30 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 24 Disintegrants & Superdisintegrants, 22 Controlled & Modified Release, 18 Granulation, 16 Direct Compression, 13 Thickeners and Stabilizers, 10 Lubricants & Glidants, 9 Film Formers & Plasticizers, 9 Co-Processed Excipients, 7 Solubilizers, 5 Empty Capsules, 4 Parenteral, 4 Vegetarian Capsules, 4 Taste Masking, 4 Coloring Agents, 4 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 2 Emulsifying Agents, 2 Topical, 1 Surfactant & Foaming Agents

48 Fillers, Diluents & Binders
45 Coating Systems & Additives
24 Disintegrants & Superdisintegrants
22 Controlled & Modified Release
18 Granulation
16 Direct Compression
13 Thickeners and Stabilizers
10 Lubricants & Glidants
9 Film Formers & Plasticizers
9 Co-Processed Excipients
7 Solubilizers
5 Empty Capsules
4 Parenteral
4 Vegetarian Capsules
4 Taste Masking
4 Coloring Agents
4 Rheology Modifiers
3 Chewable & Orodispersible Aids
3 API Stability Enhancers
2 Emulsifying Agents
2 Topical
1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 3 Finished Drug Prices

2 US Medicaid Prescriptions
3 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

$ API Ref.Price (USD/KG) : 14,878 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4AstraZeneca Canada Inc.

filter Patent Reset all filters

4 All

01 11340567

02 12056066

03 12056067

04 12319308

filter Product Reset all filters

4 All

01 4Zafirlukast

filter Dosage Reset all filters

4 All

01 4Tablet

filter Exp Date Reset all filters

4 All

01 32011-11-22

02 12016-06-01

Product Main Page

01

AstraZeneca Canada Inc.

Zafirlukast

The Generic Rx Session

Not Confirmed

AstraZeneca Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-22

Date Granted : 2001-08-21

Zafirlukast

Brand Name : ACCOLATE

Patent Number : 2319308

Filing Date : 1991-11-22

Strength per Unit : 20mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-11-22

Date Granted : 2001-08-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AstraZeneca Canada Inc.

Zafirlukast

The Generic Rx Session

Not Confirmed

AstraZeneca Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-22

Date Granted : 2001-09-04

Zafirlukast

Brand Name : ACCOLATE

Patent Number : 2056067

Filing Date : 1991-11-22

Strength per Unit : 20mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-11-22

Date Granted : 2001-09-04

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

AstraZeneca Canada Inc.

Zafirlukast

The Generic Rx Session

Not Confirmed

AstraZeneca Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-22

Date Granted : 2002-04-02

Zafirlukast

Brand Name : ACCOLATE

Patent Number : 2056066

Filing Date : 1991-11-22

Strength per Unit : 20mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-11-22

Date Granted : 2002-04-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

AstraZeneca Canada Inc.

Zafirlukast

The Generic Rx Session

Not Confirmed

AstraZeneca Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-06-01

Date Granted : 1999-06-01

Zafirlukast

Brand Name : ACCOLATE

Patent Number : 1340567

Filing Date : 1986-04-16

Strength per Unit : 20mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2016-06-01

Date Granted : 1999-06-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!